Skip to content
DataLookout
Menu

S2MNCT05398003

Medullary Stimulation for the Treatment of Refractory Neck Pain (S2M)

StatusRecruiting
PhaseNot applicable
Primary completion (estimated)

At risk: Primary completion moved 12 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Primary and study completion pushed from Sep 23, 2026 to Sep 23, 2027
    • Eligibility criteria expanded, about 14 words
    • Secondary endpoints: details revised at 4 of 20 entries
  2. Notable Primary and study completion dates: Sep 25, 2025 to Sep 23, 2026v3
  3. Notable Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Jun 30, 2022 to Nov 23, 2022
    • Primary and study completion dates: Apr 30, 2025 to Sep 25, 2025
    • Site details revised
    v2
  4. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Evaluating the non-inferiority of pain reduction with the combined mode compared to the low frequency reference mode.
Timeframe: 6 Months
Evaluating the overall satisfaction with the stimulation mode
Timeframe: 6 Months
Evaluating the superioty of pain reduction with the combined mode compared to the low frequency reference mode.
Timeframe: 6 Months

Secondary (17)

Evaluating the non-inferiority of patient pain with the combined mode compared to the low frequency reference mode
Evaluating the non-inferiority of patient satisfaction with their overall comfort
Evaluating the superioty of pain reduction with the combined mode compared to the low frequency reference mode.
Evaluating the non-inferiority of patient satisfaction with their overall comfort with the mode low frequency + burst vs Low frequency
Evaluating the non-inferiority of patient satisfaction with their overall comfort with the mode low frequency + high frequency vs Low frequency
Show 12 moreShow less
Evaluating the superioty of pain reduction with the combined mode (low frequency + high frequency) compared to the tonic mode (low frequency) only
Evaluating the superioty of pain reduction with the combined mode (low frequency + Burst) compared to the tonic mode (low frequency) only
Evaluate the equality of the effectiveness of the new modes (Burst, high frequency, Tonic + Burst, Tonic + high frequency) compared to the tonic mode alone on the pain criteria
Evaluate the equality of the effectiveness of the new modes (Burst, high frequency, Tonic + Burst, Tonic + high frequency) compared to the tonic mode alone on the satisfaction
Comparison of the number of recharges of the device according to the stimulation modes
Evaluating the change in the quality of life of patients at 1 month
Evaluating the change in the quality of life of patients at 3 months
Evaluating the change in the quality of life of patients at 6 months
Evaluating average daily analgesic consumption at inclusion.
Evaluating average daily analgesic consumption at 1 month
Evaluating average daily analgesic consumption at 3 months
Evaluating average daily analgesic consumption at 6 months

Arms and interventions

Study populationExperimental

12 patients with neck and upper limb pain who have failed multidisciplinary treatment and are candidates for cervical medullary stimulation will be included.

Devices: Implantation of the WAVEWRITER ALPHA ™ device

Sites

1 site in 1 country

  • CHU de NantesNantes, France